Finance

Lists
5JA1:FRA
Sprint Bioscience AB
€0.28
+0.73%
(+0.0020) 1D
Sep 4, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 5JA1...
Open
€0.28
High
€0.28
Low
€0.28
Mkt. cap
342.93M
Avg. vol.
153.00
Volume
0.00
52-wk high
€0.38
52-wk low
€0.03
No. of employees
32
Open
€0.28
High
€0.28
Low
€0.28
Mkt. cap
342.93M
Avg. vol.
153.00
Volume
0.00
52-wk high
€0.38
52-wk low
€0.03
No. of employees
32
About Sprint Bioscience AB
CEO-
Employees32
Founded2009
Headquarters-
SectorBiotechnology
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.24M
134.13M
-
5.00K
Cost of goods sold
1.81M
1.06M
1.44M
3.06M
Cost of revenue
1.81M
1.06M
1.44M
3.06M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.58M
15.04M
12.63M
13.23M
Operating expense
11.86M
14.79M
12.93M
13.52M
Total operating expenses
13.66M
15.85M
14.36M
16.59M
Operating income
-8.43M
118.28M
-14.36M
-16.58M
Other non operating income
29.00K
-505.00K
53.00K
-
EBT including unusual items
-8.42M
113.18M
-12.89M
-16.21M
EBT excluding unusual items
-8.42M
113.18M
-12.89M
-16.21M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
6.00K
-512.00K
25.00K
10.00K
Net income
-8.42M
113.18M
-12.89M
-16.21M
Net profit margin
-160.82%
84.38%
-
-324,140.00%
Earnings per share
-
-
-
-
Interest and investment income
69.00K
1.44M
1.49M
620.00K
Interest expense
-95.00K
-
-69.00K
-246.00K
Net interest expenses
-26.00K
1.44M
1.42M
374.00K
Depreciation and amortization charges
268.00K
269.00K
270.00K
280.00K
EBITDA
-8.16M
118.54M
-14.09M
-16.30M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps